Taken together, this may mean that Foxp3-mediated inhibition of RORγt prevails under non-inflammatory conditions, whereas RORγt and RORγt suppression of Foxp3 predominate in the specific inflammatory milieu present in the tissues in the state of IBD. Here, FOXP3 is linked to inflammatory bowel disease.